UroGen Pharma Analyst Ratings

BenzingaMar 13 07:28 ET

Raymond James Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $36

Moomoo NewsMar 12 07:31 ET

H.C. Wainwright Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $55

Moomoo NewsMar 11 11:31 ET

UroGen Pharma Price Target Cut to $55.00/Share From $64.00 by HC Wainwright & Co.

Dow JonesMar 11 07:01 ET

TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsMar 10 14:32 ET

D. Boral Capital Maintains Buy on UroGen Pharma, Maintains $25 Price Target

BenzingaMar 10 10:37 ET

UroGen Pharma Analyst Ratings

BenzingaMar 10 10:36 ET

H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $64

Moomoo NewsFeb 25 07:33 ET

UroGen Pharma Analyst Ratings

BenzingaFeb 21 02:53 ET

D. Boral Capital Maintains Buy on UroGen Pharma, Maintains $25 Price Target

BenzingaFeb 20 17:35 ET

Ladenburg Thalmann Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $31

Moomoo NewsFeb 19 07:33 ET

D. Boral Capital Maintains Buy on UroGen Pharma, Maintains $25 Price Target

BenzingaFeb 12 10:17 ET

UroGen Pharma Analyst Ratings

BenzingaFeb 12 10:16 ET

UroGen Pharma Is Maintained at Buy by D. Boral Capital

Dow JonesDec 6, 2024 07:26 ET

UroGen Pharma Price Target Maintained With a $25.00/Share by D. Boral Capital

Dow JonesDec 6, 2024 07:26 ET

UroGen Pharma Analyst Ratings

BenzingaDec 6, 2024 07:17 ET

TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $35

Moomoo NewsNov 6, 2024 15:31 ET

UroGen Pharma Analyst Ratings

BenzingaNov 6, 2024 11:20 ET

EF Hutton Maintains Buy on UroGen Pharma, Maintains $25 Price Target

BenzingaNov 6, 2024 11:20 ET

UroGen Pharma Price Target Maintained With a $25.00/Share by EF Hutton

Dow JonesOct 29, 2024 07:32 ET